GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngen Biotech Co Ltd (ROCO:8279) » Definitions » Cyclically Adjusted PS Ratio

Syngen Biotech Co (ROCO:8279) Cyclically Adjusted PS Ratio : 2.71 (As of Jun. 25, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Syngen Biotech Co Cyclically Adjusted PS Ratio?

As of today (2024-06-25), Syngen Biotech Co's current share price is NT$160.00. Syngen Biotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was NT$58.97. Syngen Biotech Co's Cyclically Adjusted PS Ratio for today is 2.71.

The historical rank and industry rank for Syngen Biotech Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:8279' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.54   Med: 2.67   Max: 2.95
Current: 2.76

During the past years, Syngen Biotech Co's highest Cyclically Adjusted PS Ratio was 2.95. The lowest was 2.54. And the median was 2.67.

ROCO:8279's Cyclically Adjusted PS Ratio is ranked better than
66.07% of 504 companies
in the Biotechnology industry
Industry Median: 5.225 vs ROCO:8279: 2.76

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Syngen Biotech Co's adjusted revenue per share data for the three months ended in Mar. 2024 was NT$17.240. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$58.97 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Syngen Biotech Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Syngen Biotech Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngen Biotech Co Cyclically Adjusted PS Ratio Chart

Syngen Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.78

Syngen Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.88 2.78 2.67

Competitive Comparison of Syngen Biotech Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Syngen Biotech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngen Biotech Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngen Biotech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Syngen Biotech Co's Cyclically Adjusted PS Ratio falls into.



Syngen Biotech Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Syngen Biotech Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=160.00/58.97
=2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngen Biotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Syngen Biotech Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=17.24/131.7762*131.7762
=17.240

Current CPI (Mar. 2024) = 131.7762.

Syngen Biotech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.000 98.326 0.000
201406 0.000 100.560 0.000
201412 0.000 99.070 0.000
201503 8.851 99.621 11.708
201506 7.944 100.684 10.397
201509 7.682 100.392 10.084
201512 8.194 99.792 10.820
201603 7.898 100.470 10.359
201606 8.919 101.688 11.558
201609 9.972 101.861 12.901
201612 8.856 101.863 11.457
201703 8.683 102.862 11.124
201706 9.559 103.349 12.188
201709 11.543 104.136 14.607
201712 9.779 104.011 12.389
201803 8.176 105.290 10.233
201806 11.162 106.317 13.835
201809 13.364 106.507 16.535
201812 13.586 105.998 16.890
201903 11.437 107.251 14.052
201906 15.331 108.070 18.694
201909 15.088 108.329 18.354
201912 12.340 108.420 14.998
202003 9.868 108.902 11.941
202006 13.641 108.767 16.527
202009 12.592 109.815 15.110
202012 12.250 109.897 14.689
202103 11.258 111.754 13.275
202106 14.155 114.631 16.272
202109 12.901 115.734 14.689
202112 15.935 117.630 17.851
202203 13.960 121.301 15.166
202206 18.240 125.017 19.226
202209 19.997 125.227 21.043
202212 18.950 125.222 19.942
202303 16.373 127.348 16.942
202306 16.990 128.729 17.392
202309 17.401 129.860 17.658
202312 17.011 129.419 17.321
202403 17.240 131.776 17.240

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Syngen Biotech Co  (ROCO:8279) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Syngen Biotech Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Syngen Biotech Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngen Biotech Co (ROCO:8279) Business Description

Traded in Other Exchanges
N/A
Address
Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.

Syngen Biotech Co (ROCO:8279) Headlines

No Headlines